LT

Leafy Tunnel

Europe, England, United Kingdom, London

Description

Leafy Tunnel is an early-stage fund investing in European medical cannabis and global medical psychedelics companies.

Investor Profile

Leafy Tunnel has made 4 investments, with 0 in the past 12 months and 50% as lead.

Stage Focus

  • Seed (50%)
  • Series B (25%)
  • Series A (25%)

Country Focus

  • United Kingdom (50%)
  • United States (50%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Life Science
  • Machine Learning
  • Health Diagnostics
  • Medical Device
  • Software
  • Cannabis
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Leafy Tunnel frequently co-invest with?

FJ Labs
North America, New York, United States, New York
Co-Investments: 1
Negev Capital
North America, Midland, Cayman Islands, Grand Cayman
Co-Investments: 1
Adage Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
BD
North America, California, United States, San Francisco
Co-Investments: 1
Prime Movers Lab
North America, Wyoming, United States, Jackson
Co-Investments: 1
PsyMed Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Ayuh Ventures
North America, Delaware, United States, Dover
Co-Investments: 1
PS
North America, Illinois, United States, Highland Park
Co-Investments: 1
Delphi VC
North America, New York, United States, New York
Co-Investments: 1
Oryx Ventures
Asia, Dubai, United Arab Emirates, Dubai
Co-Investments: 1

Which angels does Leafy Tunnel often collaborate with?

Shared Deals: 1
ZR
North America, California, United States, Redwood City
Shared Deals: 1
CN
North America, New York, United States, New York
Shared Deals: 1
CF
Europe, United Kingdom
Shared Deals: 1
NL
North America, New York, United States
Shared Deals: 1
MM
North America, Florida, United States
Shared Deals: 1

What are some of recent deals done by Leafy Tunnel?

Ceretype Neuromedicine

Cambridge, Massachusetts, United States

Ceretype Neuromedicine is a next-generation fMRI brain biomarker platform to improve drug discovery and patient care in neuropsychiatry

BiotechnologyHealth CareLife ScienceMachine LearningMedical
SeedJan 1, 2024
Amount Raised: $2,000,000
Lyphe group

London, England, United Kingdom

Lyphe group is a reliable supplier of medical cannabis care and medicine.

CannabisHealth CarePharmaceutical
Series AMay 23, 2022
Amount Raised: $6,283,475
Maya Health

Denver, Colorado, United States

Maya Health is a software platform designed to track, measure, and provide illustration of the health outcomes of their clients.

Health CareHealth DiagnosticsMedical DeviceSoftware
SeedDec 17, 2021
Amount Raised: $3,500,000
Beckley Psytech

Beckley, Oxfordshire, United Kingdom

Beckley Psytech is a clinical-stage biotechnology company that explores the therapeutic potential of psychedelic substances.

BiotechnologyHealth CareMedical
Series BAug 15, 2021
Amount Raised: $80,404,797